he came with c/o sudden onset swelling of face ,arms and hands shivering + all over the body since today morning had his meals in the morning no alcohol consumption or smoking

Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
I now have solid information from Tintinalli's Emergency Medicine and Andrews' Dermatology. Let me compile the full clinical assessment.

Clinical Assessment

Presenting complaints:
  • Sudden onset swelling of face, arms, and hands
  • Shivering (rigors) all over the body - since this morning
  • Had morning meals (possible food trigger)
  • No alcohol, no smoking

Most Likely Diagnosis: Anaphylaxis / Allergic Reaction with Angioedema

The constellation of sudden-onset facial + extremity swelling following a meal, combined with systemic symptoms (rigors/shivering), strongly points to an anaphylactic/allergic reaction - possibly food-triggered.

Why this fits:

FeatureSignificance
Sudden onset after mealsFood allergen trigger (peanuts, shellfish, eggs, soy, milk are most common)
Facial swellingAngioedema - deep dermal/subcutaneous edema in highly distensible tissue
Arm + hand swellingPeripheral angioedema - classic distribution
Rigors/shiveringSystemic mast cell/basophil activation; can also indicate early sepsis if fever present
No alcoholAlcohol can sometimes be a cofactor in allergic reactions - its absence is noted
Per Andrews' Diseases of the Skin: "Angioedema is an acute, evanescent, circumscribed edema that usually affects the most distensible tissues, such as the eyelids, lips, earlobes... There may be a diffuse swelling on the hands, forearms, feet, and ankles."
Per Tintinalli's Emergency Medicine: Food-triggered anaphylaxis symptoms typically occur within 5 to 30 minutes of ingestion, though reactions to mammalian foods (beef, pork) can be delayed 3-6 hours.

Differential Diagnoses to Consider

  1. Anaphylaxis (food-triggered) - Most likely. Rigors + angioedema post-meal.
  2. Hereditary Angioedema (HAE) - Autosomal dominant C1 esterase inhibitor deficiency. Attacks of swelling (face, hands, arms) WITHOUT urticaria or pruritus. Triggered by minor stress. Ask: family history? recurrent attacks? abdominal pain episodes?
  3. ACE inhibitor-induced angioedema - Ask about any antihypertensive medications. 0.1-0.7% incidence. NOT responsive to antihistamines/epinephrine.
  4. Sepsis with early distributive phase - Rigors are a hallmark of bacteremia/septicemia. The facial swelling is less typical here - but must rule out.
  5. Drug reaction - Any new medication? NSAIDs taken with morning meal?

Immediate Assessment Priorities

CRITICAL - Airway First

Angioedema of the tongue, lips, and face carries risk of airway obstruction - which can develop rapidly and unpredictably. (Tintinalli's)
Ask/Check:
  • Any throat tightness, stridor, hoarseness, difficulty swallowing?
  • Tongue or lip swelling?
  • Breathing difficulty?
  • Blood pressure (hypotension = anaphylaxis)
  • Rash, urticaria, pruritus?
  • SpO2

History to Elicit

QuestionReason
What exactly did he eat?Identify food allergen
Any previous similar episodes?HAE or recurrent allergy
Any medications taken today or recently?ACE inhibitors, NSAIDs, antibiotics
Family history of swelling episodes?HAE (autosomal dominant)
Any insect bite/sting recently?Hymenoptera venom anaphylaxis
Fever present?Sepsis vs. allergic reaction
Abdominal pain, nausea, vomiting?Anaphylaxis GI involvement / HAE abdominal crisis
Pruritus / urticaria?Allergic (histamine-mediated) vs. bradykinin-mediated (HAE, ACE-i)

Emergency Management (if anaphylaxis confirmed)

1st Line - Epinephrine (MANDATORY if anaphylaxis)

  • Epinephrine 0.3-0.5 mg IM (anterolateral thigh, 1:1000 concentration)
  • Repeat every 5-15 min as needed
  • Do NOT delay for antihistamines or steroids

Supportive

  • IV access - large bore, normal saline bolus if hypotensive
  • Oxygen - high flow if SpO2 decreased
  • Antihistamines - H1 (diphenhydramine 25-50 mg IV/IM) + H2 (ranitidine 50 mg IV)
  • Corticosteroids - Hydrocortisone 200 mg IV or Methylprednisolone 1-2 mg/kg IV (reduces biphasic reaction risk)
  • Monitor for biphasic anaphylaxis (recurrence 1-72 hours later)
  • Observe for minimum 4-6 hours after reaction

If HAE suspected (no urticaria, no pruritus, family history, no response to above):

  • C1 esterase inhibitor concentrate (Berinert 20 U/kg IV)
  • Icatibant 30 mg SC (bradykinin-2 receptor antagonist)
  • Note: Antihistamines, epinephrine, and corticosteroids have minimal effect on HAE

Red Flags - Call for Immediate Escalation

  • Stridor / voice change / throat tightness - prepare for intubation
  • SpO2 < 94%
  • Hypotension (SBP < 90 mmHg)
  • Loss of consciousness
  • Rapidly worsening swelling

Sources: Tintinalli's Emergency Medicine (pp. 113, 2386-2387); Andrews' Diseases of the Skin (pp. 179)

Search for latest anaphylaxis treatment guidelines and protocols

Searching PubMed

anaphylaxis treatment guidelines management

Searching the Web

anaphylaxis treatment guidelines 2024 2025 WAO AAAAI epinephrine protocol

Finding Sources
Reading Article

PMID: 41117568

Reading Article

PMID: 42335666

Reading Web Page

https://pmc.ncbi.nlm.nih.gov/articles/PMC12402951

Searching PubMed

anaphylaxis epinephrine first-line treatment protocol

Searching PubMed

anaphylaxis epinephrine adrenaline management 2024

Searching the Web

WAO anaphylaxis guidelines 2024 2025 diagnosis criteria management steps

Finding Sources
Reading Article

PMID: 39880313

Reading Article

PMID: 38866583

Reading Web Page

https://phoenixchildrens.org/sites/default/files/2025-11/ana…

Here is a fully synthesized summary of the latest anaphylaxis treatment guidelines and protocols, drawing from the 2024 GA²LEN International Consensus (PMID 39880313), WAO 2026 White Book, ERC Guidelines 2025, SFAR/SFA Perioperative Guidelines 2025 (PMID 42335666), and recent systematic reviews.

Anaphylaxis Treatment Guidelines & Protocols (2024-2026)


1. Updated Diagnostic Criteria (GA²LEN 2024 Consensus)

The 2024 GA²LEN International Consensus (Dribin et al., JACI 2025) replaced the older 2006 NIAID/FAAN and 2020 WAO criteria with a unified definition:
"Anaphylaxis is a serious allergic (hypersensitivity) reaction that can progress rapidly and may cause death."
Anaphylaxis is highly likely when at least ONE of these 2 criteria is met (usually within minutes to 2-3 hours of allergen exposure):
CriterionFeatures
Criterion 1Acute onset involving skin/mucosal tissue (hives, flushing, lip/tongue/uvula swelling) AND at least one of: respiratory compromise, reduced BP/end-organ dysfunction, severe GI symptoms
Criterion 2Acute onset of hypotension, bronchospasm, or laryngeal involvement after exposure to a known or likely allergen - even without skin signs
Key update: Skin involvement is no longer required to diagnose anaphylaxis. Cardiovascular or respiratory symptoms alone after allergen exposure are sufficient.
Serum tryptase measurement is now formally recommended to confirm diagnosis and identify underlying mast cell disorders (mastocytosis).

2. Severity Grading (WAO 2024 Updated System)

WAO's joint committee updated the grading system in 2024 (World Allergy Organ J, 2024):
GradeFeatures
Grade 1 (Mild)Cutaneous/mucosal only - no systemic signs
Grade 2 (Moderate)Systemic symptoms but no life-threatening involvement
Grade 3 (Severe)Life-threatening cardiovascular or respiratory compromise
Grade 4 (Arrest)Cardiac or respiratory arrest
Epinephrine should be given regardless of grade - grading mainly guides monitoring intensity and adjunct therapies.

3. Treatment Protocol - Step by Step

STEP 1: Call for Help / Activate Emergency Response

  • Lay patient flat (Trendelenburg / supine with legs elevated)
  • If breathing difficulties: semi-recumbent position
  • Pregnant patients: left lateral tilt
  • Do NOT stand a hypotensive patient upright - associated with increased mortality

STEP 2: EPINEPHRINE (Adrenaline) - THE ONLY FIRST-LINE DRUG

Intramuscular (IM) into the anterolateral thigh is the gold standard (WAO, ERC 2025, GA²LEN 2024):
PatientDoseConcentration
Adults / Children >50 kg0.5 mg (0.5 mL) IM1:1000 (1 mg/mL)
Children 20-50 kg0.3 mg (0.3 mL) IM1:1000
Children 7.5-20 kg0.15 mg IM1:1000
Children <7.5 kg0.01 mg/kg IM1:1000
  • Repeat every 5-15 minutes if no response - up to 3 doses IM
  • IV epinephrine only in refractory/severe cases with cardiovascular monitoring in place (higher risk of arrhythmias - use IV only in ICU/resus settings)
  • New 2024-2025: Intranasal epinephrine spray (neffy®) has been approved and shows pharmacokinetics equivalent to IM injection - useful when IM access is difficult, especially in community settings
⚠️ Antihistamines and corticosteroids are adjuncts only - NOT first-line. Giving them before epinephrine causes dangerous delays and is associated with deaths.

STEP 3: Positioning & IV Access

  • Establish large-bore IV access
  • IV crystalloid bolus (normal saline): 10-20 mL/kg rapidly if hypotensive
  • Continuous monitoring: SpO2, ECG, BP every 5 minutes

STEP 4: Oxygen

  • High-flow oxygen (10-15 L/min via face mask) if SpO2 <90% or respiratory distress
  • Nebulized albuterol (salbutamol) for bronchospasm not resolving after epinephrine

STEP 5: Adjunct Medications (after epinephrine)

DrugDoseRole
H1 antihistamine (diphenhydramine/cetirizine)25-50 mg IV/IM (adults)Relieves urticaria/pruritus only - NOT life-saving
H2 antihistamine (ranitidine/famotidine)50 mg IVAdjunct for urticaria
Corticosteroids (hydrocortisone/methylprednisolone)Hydrocortisone 200 mg IV or Methylprednisolone 1-2 mg/kg IVReduce risk of biphasic/prolonged reaction - NOT proven to prevent it
Glucagon1-2 mg IV over 5 min (then infusion)For patients on beta-blockers who don't respond to epinephrine
Vasopressors (norepinephrine, vasopressin)Per ICU protocolRefractory anaphylaxis with persistent hypotension

STEP 6: Refractory Anaphylaxis (2024 Review - Pouessel et al., Clin Exp Allergy)

For patients not responding to 3 doses of IM epinephrine:
  1. IV epinephrine infusion: 0.1-1 mcg/kg/min (in monitored setting)
  2. Aggressive IV fluid resuscitation - up to 4-5L may be needed
  3. Second-line vasopressors: norepinephrine (preferred), vasopressin, dopamine
  4. Methylene blue: suggested in refractory vasodilatory shock
  5. Extracorporeal life support (ECLS/ECMO): rescue therapy in cardiac arrest from anaphylaxis
  6. Genetic factors to investigate: platelet activating factor-acetylhydrolase deficiency, hereditary alpha-tryptasemia, mastocytosis

4. Airway Management

  • Stridor, hoarseness, or voice change = immediate preparation for advanced airway
  • Nebulized racemic epinephrine for upper airway edema
  • Early intubation if impending obstruction - delay is dangerous as edema progresses rapidly
  • Consider surgical airway (cricothyrotomy) if intubation fails in severe laryngeal edema

5. Observation Period

SituationObservation
Mild reaction, single epinephrine dose, responds fullyMinimum 4 hours
Moderate-severe, 2+ epinephrine doses6-12 hours minimum
History of biphasic reactions, severe presentationAdmit overnight (12-24 hours)
Asthma + anaphylaxis, cardiovascular involvementICU admission
Biphasic anaphylaxis (recurrence 1-72 hours later) occurs in ~5-20% of cases - monitoring is mandatory.

6. Discharge & Long-Term Management

All patients discharged after anaphylaxis must receive:
  1. Epinephrine autoinjector prescription (2 devices - one for immediate use, one as backup)
  2. Written anaphylaxis action plan
  3. Allergen avoidance counseling (identify and label known trigger)
  4. Allergy/immunology referral for trigger workup
  5. Serum tryptase at follow-up (to rule out mastocytosis in severe/recurrent cases)
  6. For insect venom anaphylaxis: consider venom immunotherapy (highly effective for long-term prevention)
  7. Consider omalizumab for refractory/recurrent idiopathic anaphylaxis (EAACI 2025)

7. Special Note: ACE Inhibitor-Induced Angioedema

If swelling is due to ACE inhibitors (bradykinin-mediated, NOT IgE-mediated):
  • Epinephrine, antihistamines, and steroids are largely ineffective
  • Use: Icatibant 30 mg SC (bradykinin-2 receptor antagonist) or C1 esterase inhibitor concentrate 1000 U IV

Key Sources

ALLERGIC REACTION CASE WITH REDNESS

Asking for Preferences
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Loading Image
Finding Sources
Loading Image
Loading Image
Finding Sources
Here is the complete clinical breakdown for this case - allergic reaction with redness (erythema/flushing) + angioedema over face/neck and arms/hands.

Allergic Reaction with Redness + Angioedema

Face/Neck + Arms/Hands | Unknown Trigger


What You Are Seeing - Urticaria with Angioedema

The redness in this case is erythema - the cutaneous hallmark of histamine-mediated allergic reactions. It accompanies angioedema (deep tissue swelling), forming one of the most common emergency presentations.
Classic urticarial wheals - what they look like:
Confluent erythematous wheals - early urticaria:
Urticaria - confluent erythematous wheals on skin
Urticaria with annular/ring-shaped wheals spreading across body:
Urticaria - annular pink wheals over torso and arms

Pathophysiology

Trigger (food/drug/unknown)
         ↓
IgE on mast cells/basophils cross-linked
         ↓
Degranulation → Histamine, leukotrienes, prostaglandins
         ↓
H1 receptor activation on cutaneous vessels
         ↓
Vasodilation → ERYTHEMA (redness/flushing)
Vascular leak in superficial dermis → WHEALS (urticaria)
Vascular leak in deep dermis/subcut → ANGIOEDEMA (swelling)
Redness specifically = vasodilation of superficial dermal capillaries from histamine binding H1 receptors. It is the first visible sign, often appearing as a flush before wheals develop.

Clinical Picture in This Patient

FeatureInterpretation
Redness - face/neckFlushing/erythema from histamine - vasodilation
Redness - arms/handsPeripheral cutaneous involvement - systemic histamine release
Swelling (angioedema)Deep dermal/subcutaneous vascular leak
Combined urticaria + angioedemaHistaminergic (allergic) - IgE-mediated pattern
Unknown triggerIdiopathic - most common category in adults
Per Rosen's Emergency Medicine: "Angioedema that occurs in conjunction with urticaria is typically histaminergic (allergic) in nature."
Per Tintinalli's Emergency Medicine: "The urticarial wheals are white, pink, or erythematous non-scaling lesions that range in size from <1 cm to >10 cm. The pattern can be annular, serpiginous, or confluent."

FIRST - Assess for Anaphylaxis (MANDATORY)

Before treating as simple urticaria, rule out anaphylaxis:
QuestionSignAction if Present
Throat tightness/stridor?Laryngeal angioedemaEPINEPHRINE IMMEDIATELY
Breathing difficulty/wheeze?BronchospasmEpinephrine + Salbutamol
Hypotension/dizziness?Distributive shockEpinephrine + IV fluids
Tongue/lip swelling?Airway riskPrepare for intubation
If ANY of the above are present → treat as anaphylaxis (see previous protocol). Epinephrine first, everything else second.

Management: Allergic Reaction WITHOUT Anaphylaxis Features

Step 1: H1 Antihistamines (FIRST LINE)

DrugDoseRouteNotes
Cetirizine (preferred)10-20 mgPO/IV2nd generation - non-sedating, fast onset
Loratadine10-20 mgPONon-sedating
Fexofenadine180 mgPONon-sedating
Diphenhydramine25-50 mgPO/IV/IM1st gen - sedating, useful for severe/acute itch
Hydroxyzine25-50 mgPO/IM1st gen - sedating, nighttime use
Up to 4x the standard dose of 2nd generation antihistamines may be used for poorly controlled reactions (Rosen's EM).

Step 2: H2 Antihistamines (ADD-ON)

  • Ranitidine 50 mg IV or Famotidine 20 mg IV - 15% of dermal histamine receptors are H2; adding H2 blockade improves response
  • Do NOT use as monotherapy

Step 3: Corticosteroids (for moderate-severe or widespread redness/angioedema)

  • Prednisone 40-60 mg PO daily for 5-7 days
  • Hydrocortisone 200 mg IV if unable to take oral
  • Role: reduce prolonged/recurrent reactions; do NOT give before antihistamines
  • Note: A double-blind RCT showed no additional benefit of prednisone over levocetirizine alone in acute urticaria ≤24 hrs - use clinical judgment

Step 4: Epinephrine (for severe urticaria/angioedema even without full anaphylaxis)

  • 0.3-0.5 mg IM (anterolateral thigh) if symptoms are rapid/severe or worsening
  • Do not withhold if there is any concern about progression

Causes to Consider (for Unknown Trigger Workup)

CategoryExamples
FoodsPeanut, shellfish, tree nuts, egg, milk, soy, wheat
DrugsPenicillin/beta-lactams, NSAIDs, aspirin, radiocontrast, opioids
InfectionsViral (most common cause in children), bacterial
PhysicalCold, pressure, heat, exercise, sunlight
Insect stingHymenoptera (bee, wasp)
LatexContact urticaria - healthcare workers, surgical gloves
Alpha-gal syndromeDelayed urticaria 3-6 hrs after red meat - tick bite sensitization
IdiopathicUp to 60% of adult cases - no trigger found

Key Differentials for Redness + Swelling

ConditionDistinguishing Feature
Urticaria + angioedema (this case)Pruritic, transient wheals <24 hrs, erythematous
Hereditary angioedemaNO urticaria/itch, recurrent, family history, no response to antihistamines
Contact dermatitisFixed location, follows contact pattern, scaling possible
Erythema multiformeNOT pruritic or transient - target lesions, mucosal involvement
CellulitisWarm, tender, non-pruritic, fever, unilateral
Angio-oedema from ACE inhibitorNo urticaria, bradykinin-mediated, ACE-i history

Disposition

ScenarioAction
Mild - urticaria + minor swelling, no airway/BP involvementAntihistamines PO, observe 1-2 hrs, discharge with follow-up
Moderate - widespread redness, significant angioedemaIV antihistamines + steroids, observe 4-6 hrs
Severe - facial/tongue/laryngeal swellingEpinephrine IM + hospital admission, airway monitoring
Any anaphylaxis featureMinimum 4-hour observation post-epinephrine
Discharge counseling:
  • Avoid suspected trigger
  • Prescribe oral antihistamines (cetirizine 10 mg BD x 5-7 days)
  • Consider short steroid course if angioedema present
  • Allergy referral for trigger identification (skin prick test / specific IgE)
  • Prescribe epinephrine autoinjector if reaction was severe or trigger unclear

Sources: Andrews' Diseases of the Skin (p. 144); Tintinalli's Emergency Medicine (p. 1686); Rosen's Emergency Medicine (p. 2394)
This is a shared conversation. Sign in to Orris to start your own chat.